Form 4 holding
Director
MAXCYTE, INC.
- Security class
- Common Stock
- Shares / value
- 395,851
- Estimated value
- $1,940,066
- Report date
- 11 Jun 2024
- Price
- $4.90
- Ownership
- Direct
Art Mandell
Insider Reports History
- Location
- Gaithersburg, MD
- Reporting signature
- /s/ Brian Leaf, Attorney-in-Fact
- Transaction evidence
- Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
SEC record
SEC evidence
Holdings reported by Art Mandell:
Form 4 holding
Director
MAXCYTE, INC.
- Security class
- Stock Option (right to buy)
- Shares / value
- 40,701
- Estimated value
- Report date
- 11 Jun 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Art Mandell
4
MXCT
MAXCYTE, INC.
- Report period
- 11 Jun 2024
- Transactions
- 2
- Transaction value
- $0
- Filing time
- 13 Jun 2024, 17:41
- Role
- Director
- Next action
- Open filing details
4
MXCT
MAXCYTE, INC.
- Report period
- 22 Jun 2023
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 23 Jun 2023, 17:17
- Role
- Director
- Next action
- Open filing details
4
MXCT
MAXCYTE, INC.
- Report period
- 29 Jun 2022
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 08 Jul 2022, 16:02
- Role
- Director
- Next action
- Open filing details
4
MXCT
MAXCYTE, INC.
- Report period
- 09 Aug 2021
- Transactions
- 1
- Transaction value
- $0
- Filing time
- 11 Aug 2021, 17:17
- Role
- Director
- Next action
- Open filing details
3
MXCT
MAXCYTE, INC.
- Report period
- 29 Jul 2021
- Transactions
- 0
- Transaction value
- $0
- Filing time
- 29 Jul 2021, 18:41
- Role
- Director
- Next action
- Open filing details